FDA APPROVES NEW CLASS OF PAINKILLER – THE FIRST IN MORE THAN 20 YEARS

Summary from the TLDR newsletter

The US Food and Drug Administration has approved the use of a novel painkiller called suzetrigine for the treatment of short-term moderate-to-severe pain in adults. The new drug is the first of a new class of analgesics that aren't addictive. It selectively targets a sodium channel critical to pain signaling in the peripheral nervous system, inhibiting pain signals from being sent to the brain. The drug is not an opioid, which means that medical professionals now have an alternative to treating pain that doesn't require using a potentially addictive analgesic.